The JSE faces muted Asian markets on Tuesday morning, amid more good news regarding a Covid-19 vaccine.
Moderna’s vaccine candidate, requiring less refrigeration, appears to be more efficacious than that of Pfizer's and BioNtech announced last week, when risk assets rallied...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.